BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

9.90

-0.18 (-1.79%)

At close: Sep 5, 2025, 4:00 PM

10.23

+0.33 (3.33%)

After-hours: Sep 5, 2025, 7:59 PM EDT

BBOT Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-87.5	-74.28	-64.7
Depreciation & Amortization	0.34	0.21	0.09
Loss (Gain) From Sale of Investments	-2.13	-1.54	-
Stock-Based Compensation	2.86	4.43	16.47
Other Operating Activities	1.29	0.56	-
Change in Accounts Payable	1.46	2.5	0.27
Change in Other Net Operating Assets	2.78	13.1	-4.2
Operating Cash Flow	-80.9	-55.03	-52.08
Capital Expenditures	-0.41	-0.05	-0.41
Investment in Securities	54	-122.89	-
Other Investing Activities	-	2.41	-2.41
Investing Cash Flow	53.59	-120.53	-2.82
Issuance of Common Stock	0.05	1.11	3.62
Financing Cash Flow	18.6	206.29	55.12
Net Cash Flow	-8.71	30.73	0.23
Free Cash Flow	-81.31	-55.08	-52.49
Free Cash Flow Per Share	-249.57	-379.51	-420.87
Levered Free Cash Flow	-	-42.53	-
Unlevered Free Cash Flow	-	-42.53	-
Change in Working Capital	4.24	15.59	-3.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.